Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
申请人:Aventis Pharmaceuticals Inc.
公开号:US06194406B1
公开(公告)日:2001-02-27
The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula (1):
and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
本发明涉及新型4-(1H-苯并咪唑-2-基)[1,4]二氮杂烷衍生物的公式(1),及其立体异构体和药学上可接受的盐,其可用作组胺受体拮抗剂和快速肽受体拮抗剂。这样的拮抗剂可用于治疗过敏性鼻炎,包括季节性鼻炎和鼻窦炎;炎症性肠病,包括克罗恩病和溃疡性结肠炎;哮喘;支气管炎;和呕吐。